Open-label, Single-arm, Single Center Study Assessing the Efficacy and Safety of Ivabradine (Corlanor) in African-American/Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction

Trial Profile

Open-label, Single-arm, Single Center Study Assessing the Efficacy and Safety of Ivabradine (Corlanor) in African-American/Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Mar 2018

At a glance

  • Drugs Ivabradine (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Sponsors Amgen
  • Most Recent Events

    • 09 Mar 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top